1055 related articles for article (PubMed ID: 18043096)
21. Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era.
Porrett PM; Peterman H; Rosen M; Sonnad S; Soulen M; Markmann JF; Shaked A; Furth E; Reddy KR; Olthoff K
Liver Transpl; 2006 Apr; 12(4):665-73. PubMed ID: 16482577
[TBL] [Abstract][Full Text] [Related]
22. Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study.
Le Treut YP; Grégoire E; Klempnauer J; Belghiti J; Jouve E; Lerut J; Castaing D; Soubrane O; Boillot O; Mantion G; Homayounfar K; Bustamante M; Azoulay D; Wolf P; Krawczyk M; Pascher A; Suc B; Chiche L; de Urbina JO; Mejzlik V; Pascual M; Lodge JP; Gruttadauria S; Paye F; Pruvot FR; Thorban S; Foss A; Adam R;
Ann Surg; 2013 May; 257(5):807-15. PubMed ID: 23532105
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis.
Ichai P; Duclos-Vallée JC; Guettier C; Hamida SB; Antonini T; Delvart V; Saliba F; Azoulay D; Castaing D; Samuel D
Liver Transpl; 2007 Jul; 13(7):996-1003. PubMed ID: 17370335
[TBL] [Abstract][Full Text] [Related]
24. [Influence of tumor characteristics on the outcome of liver transplantation among patients with hepatocellular carcinoma].
Xu Y; Fan J; Zhou J; Qiu SJ; Wu ZQ; Yu Y; Hang XW; Tang ZY; Wang YQ
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(30):2101-4. PubMed ID: 17988527
[TBL] [Abstract][Full Text] [Related]
25. Long-term patient outcome and quality of life after liver transplantation: analysis of 20-year survivors.
Duffy JP; Kao K; Ko CY; Farmer DG; McDiarmid SV; Hong JC; Venick RS; Feist S; Goldstein L; Saab S; Hiatt JR; Busuttil RW
Ann Surg; 2010 Oct; 252(4):652-61. PubMed ID: 20881772
[TBL] [Abstract][Full Text] [Related]
26. Hepatocellular carcinoma developed on compensated cirrhosis: resection as a selection tool for liver transplantation.
Scatton O; Zalinski S; Terris B; Lefevre JH; Casali A; Massault PP; Conti F; Calmus Y; Soubrane O
Liver Transpl; 2008 Jun; 14(6):779-88. PubMed ID: 18508370
[TBL] [Abstract][Full Text] [Related]
27. Improved results of transplantation for hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation.
Onaca N; Davis GL; Jennings LW; Goldstein RM; Klintmalm GB
Liver Transpl; 2009 Jun; 15(6):574-80. PubMed ID: 19479800
[TBL] [Abstract][Full Text] [Related]
28. Recurrent hepatitis C after retransplantation: factors affecting graft and patient outcome.
Carmiel-Haggai M; Fiel MI; Gaddipati HC; Abittan C; Hossain S; Roayaie S; Schwartz ME; Gondolesi G; Emre S; Schiano TD
Liver Transpl; 2005 Dec; 11(12):1567-73. PubMed ID: 16315297
[TBL] [Abstract][Full Text] [Related]
29. Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma.
Shah SA; Tan JC; McGilvray ID; Cattral MS; Cleary SP; Levy GA; Greig PD; Grant DR
Transplantation; 2006 Jun; 81(12):1633-9. PubMed ID: 16794527
[TBL] [Abstract][Full Text] [Related]
30. Single-center experience of therapeutic management of hepatic artery stenosis after orthotopic liver transplantation. Report of 20 cases.
Chen GH; Wang GY; Yang Y; Li H; Lu MQ; Cai CJ; Wang GS; Xu C; Yi SH; Zhang JF; Fu BS
Eur Surg Res; 2009; 42(1):21-7. PubMed ID: 18971582
[TBL] [Abstract][Full Text] [Related]
31. The role of liver transplantation for intrahepatic cholangiocarcinoma: a single-center experience.
Fu BS; Zhang T; Li H; Yi SH; Wang GS; Xu C; Yang Y; Cai CJ; Lu MQ; Chen GH
Eur Surg Res; 2011; 47(4):218-21. PubMed ID: 22041581
[TBL] [Abstract][Full Text] [Related]
32. Liver Transplantation for Hepatic Epithelioid Hemangioendothelioma Is Facilitated by Exception Points With Acceptable Long-term Outcomes.
Brahmbhatt M; Prenner S; Bittermann T
Transplantation; 2020 Jun; 104(6):1187-1192. PubMed ID: 31577674
[TBL] [Abstract][Full Text] [Related]
33. Post-transplant diabetes mellitus in liver transplantation: Hangzhou experience.
Xu X; Ling Q; He ZL; Gao F; Zheng SS
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):465-70. PubMed ID: 18842490
[TBL] [Abstract][Full Text] [Related]
34. HCV histological recurrence and survival following liver transplantation in patients with and without hepatocellular carcinoma.
De Martin E; Senzolo M; Boninsegna S; Guido M; Masier A; Germani G; Tomat S; Brolese A; Neri D; Cillo U; Gambato M; Russo FP; Farinati F; Burra P
Transplant Proc; 2008; 40(6):1974-5. PubMed ID: 18675104
[TBL] [Abstract][Full Text] [Related]
35. Endoluminal resection for sessile neoplasia in the GI tract is associated with a low recurrence rate and a high 5-year survival rate.
Wang AY; Ahmad NA; Zaidman JS; Brensinger CM; Lewis JD; Long WB; Kochman ML; Ginsberg GG
Gastrointest Endosc; 2008 Jul; 68(1):160-9. PubMed ID: 18577483
[TBL] [Abstract][Full Text] [Related]
36. Tumor recurrence after liver transplantation for hepatocellular carcinoma: recurrence pathway and prognostic factors.
Pérez-Saborido B; de los Galanes SJ; Menéu-Díaz JC; Romero CJ; Elola-Olaso AM; Suárez YF; Valencia VB; Moreno-González E
Transplant Proc; 2007 Sep; 39(7):2304-7. PubMed ID: 17889172
[TBL] [Abstract][Full Text] [Related]
37. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
[TBL] [Abstract][Full Text] [Related]
38. Liver transplantation for hereditary hemorrhagic telangiectasia: Report of the European liver transplant registry.
Lerut J; Orlando G; Adam R; Sabbà C; Pfitzmann R; Klempnauer J; Belghiti J; Pirenne J; Thevenot T; Hillert C; Brown CM; Gonze D; Karam V; Boillot O;
Ann Surg; 2006 Dec; 244(6):854-62; discussion 862-4. PubMed ID: 17122610
[TBL] [Abstract][Full Text] [Related]
39. Orthotopic liver transplantation for hepatic associated metabolic disorders.
Pratschke J; Steinmüller T; Bechstein WO; Neuhaus R; Tullius SG; Jonas S; Schumacher G; Luck W; Becker M; Neuhaus P
Clin Transplant; 1998 Jun; 12(3):228-32. PubMed ID: 9642515
[TBL] [Abstract][Full Text] [Related]
40. Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era.
Ravaioli M; Grazi GL; Ercolani G; Cescon M; Del Gaudio M; Zanello M; Ballardini G; Varotti G; Vetrone G; Tuci F; Lauro A; Ramacciato G; Pinna AD
Transplantation; 2006 Feb; 81(4):525-30. PubMed ID: 16495798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
